SCHEMBL20397513

SCHEMBL20397513

CC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB2 P05107 3/20 0.50
▸ ICAM1 P05362 3/20 0.50
▸ ITGAL P20701 3/20 0.50
▸ REN P00797 5/20 0.49
▸ SLC15A2 Q16348 1/20 0.48
▸ ACE2 Q9BYF1 2/20 0.48
▸ SLC6A5 Q9Y345 1/20 0.45
▸ CA1 P00915 3/20 0.45
▸ CA2 P00918 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ THPO P40225 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9860623 0.90 ITGB2 (0.57) ITGB2ICAM1ITGALRENSLC15A2
SCHEMBL15683044 0.85 ITGB2 (0.64) ITGB2ICAM1ITGALRENSLC15A2
SCHEMBL468830 0.85 ITGB2 (0.64) ITGB2ICAM1ITGALRENSLC15A2
SCHEMBL6026427 0.85 ITGB2 (0.64) ITGB2ICAM1ITGALRENSLC15A2
Water SCHEMBL8680774 0.83 ITGB2 (0.63) ITGB2ICAM1ITGALRENSLC15A2
SCHEMBL30656637 0.81 ITGB2 (0.53) ITGB2ICAM1ITGALRENSLC15A2
SCHEMBL29391246 0.81 SLC15A2 (0.56) ITGB2ICAM1ITGALRENSLC15A2
SCHEMBL11559043 0.80 ITGB2 (0.59) ITGB2ICAM1ITGALSLC15A2ACE2
SCHEMBL18862361 0.80 SLC15A2 (0.51) ITGB2ICAM1ITGALRENSLC15A2
SCHEMBL27906686 0.78 SLC15A2 (0.58) ITGB2ICAM1ITGALRENSLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210000972-A1 NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE NEWPORT SCIENTIFIC, INC. 2021-01-07 — — US disclosed
US-20180207293-A1 NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE NEWPORT SCIENTIFIC, INC. 2018-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180207293-A1 NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE UACA, CRYAA, CRYAB ITGB2 702/4885ICAM1 202/4885ITGAL 628/4885
US-20210000972-A1 NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE CHRNA1, CHRNB1, NPY1R ITGB2 1148/4885ICAM1 419/4885ITGAL 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback